International expert consensus on immunotherapy for early-stage non-small cell lung cancer

被引：16

作者：

Liang, Wenhua ^{[1
,2
]}

Cai, Kaican ^{[3
]}

Cao, Qingdong ^{[4
]}

Chen, Chun ^{[5
]}

Chen, Haiquan ^{[6
,7
]}

Chen, Jun ^{[8
]}

Chen, Ke-Neng ^{[9
]}

Chen, Qixun ^{[10
,11
]}

Chu, Tianqing ^{[12
]}

Dong, Yuchao ^{[13
]}

Fan, Jiang ^{[14
,15
]}

Fang, Wentao ^{[16
]}

Fu, Junke ^{[17
,18
]}

Fu, Xiangning

Gao, Shugeng ^{[19
]}

Ge, Di ^{[20
]}

Geng, Guojun ^{[21
]}

Geng, Qing ^{[22
]}

He, Jie ^{[19
]}

Hu, Jian ^{[23
]}

Hu, Jie ^{[24
,25
]}

Hu, Wei-Dong

Jiang, Feng ^{[26
,27
,28
]}

Jiang, Tao ^{[29
]}

Jiao, Wenjie ^{[30
]}

Li, He-Cheng ^{[31
]}

Li, Qiang ^{[32
]}

Li, Shanqing ^{[33
]}

Li, Shuben ^{[1
,2
]}

Li, Xiangnan ^{[34
]}

Liao, Yong-De ^{[35
]}

Liu, Changhong ^{[36
]}

Liu, Hongxu ^{[37
]}

Liu, Yang ^{[38
]}

Lu, Zhuming ^{[39
]}

Luo, Qingquan ^{[40
]}

Ma, Haitao ^{[41
]}

Pan, Xiaojie ^{[42
]}

Qiao, Guibin ^{[43
,44
]}

Ren, Shengxiang ^{[45
]}

Shen, Weiyu ^{[46
]}

Song, Yong ^{[47
]}

Sun, Daqiang ^{[48
]}

Wang, Guangsuo ^{[49
]}

Wang, Jie ^{[50
]}

Wang, Mengzhao ^{[51
]}

Wang, Qiwen ^{[52
]}

Wang, Wen-Xiang ^{[53
]}

Wei, Li ^{[54
]}

Wu, Ming ^{[55
]}

机构：

[1] Guangzhou Med Univ, Dept Thorac Surg & Oncol, State Key Lab Resp Dis, Natl Ctr Resp Med,Affiliated Hosp 1, Guangzhou, Peoples R China

[2] Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China

[3] Southern Med Univ, Nanfang Hosp, Dept Thorac Surg, Guangzhou, Peoples R China

[4] Sun Yat Sen Univ, Dept Thorac Surg, Affiliated Hosp 5, Zhuhai, Peoples R China

[5] Fujian Med Univ, Dept Thorac Surg, Union Hosp, Fuzhou, Peoples R China

[6] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai, Peoples R China

[7] Fudan Univ, State Key Lab Genet Engn, Shanghai Canc Ctr, Shanghai, Peoples R China

[8] Tianjin Med Univ, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Dept Lung Canc Surg,Gen Hosp, Tianjin, Peoples R China

[9] Peking Univ Canc Hosp & Inst, Dept Thorac Surg, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

[10] Univ Chinese Acad Sci, Dept Thorac Surg, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China

[11] Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China

[12] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Sch Med, Shanghai, Peoples R China

[13] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Resp & Crit Care Med, Affiliated Hosp 5, Shanghai, Peoples R China

[14] Tongji Univ, Shanghai Pulm Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China

[15] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Thorac Surg, Shanghai, Peoples R China

[16] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China

[17] Xi An Jiao Tong Univ, Dept Thorac Surg, Affiliated Hosp 1, Xian, Peoples R China

[18] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Peoples R China

[19] Chinese Acad Med Sci & Peking Union Med Coll, Thorac Surg Dept, Natl Canc Ctr, Natl Clin Res Ctr,Canc Canc Hosp, Beijing, Peoples R China

[20] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China

[21] Fujian Med Univ, Xiamen Key Lab Thorac Tumor Diag & Treatment, Xiamen Univ,Affiliated Hosp 1, Sch Clin Med,Dept Thorac Surg,Inst Lung Canc, Xiamen, Peoples R China

[22] Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan, Peoples R China

[23] Zhejiang Univ, Affiliated Hosp 1, Dept Thorac Surg, Sch Med, Hangzhou, Peoples R China

[24] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China

[25] Wuhan Univ, Dept Thorac Surg, Zhongnan Hosp, Wuhan, Peoples R China

[26] Nanjing Med Univ, Dept Thorac Surg, Affiliated Canc Hosp, Nanjing, Peoples R China

[27] Jiangsu Canc Hosp, Nanjing, Peoples R China

[28] Jiangsu Inst Canc Res, Nanjing, Peoples R China

[29] Air Force Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China

[30] Qingdao Univ, Dept Thorac Surg, Affiliated Hosp, Qingdao, Peoples R China

[31] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China

[32] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Dept Thorac Surg, Chengdu, Peoples R China

[33] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Thorac Surg, Beijing, Peoples R China

[34] Zhengzhou Univ, Dept Thorac Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China

[35] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Peoples R China

[36] Dalian Med Univ, Dept Thorac Surg, Hosp 2, Dalian, Peoples R China

[37] Dalian Univ Technol, China Med Univ, Liaoning Canc Hosp & Inst, Dept Thorac Surg,Canc Hosp, Shenyang, Peoples R China

[38] Chinese Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China

[39] Jiangmen Cent Hosp, Dept Cardiothorac Surg, Jiangmen, Peoples R China

[40] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Shanghai Lung Canc Ctr,Dept Thorac Surg, Shanghai, Peoples R China

[41] Soochow Univ, Dept Thorac Surg, Affiliated Hosp, Suzhou, Peoples R China

[42] Fujian Med Univ, Fujian Prov Hosp, Dept Thorac Surg, Shengli Clin Med Coll, Fuzhou, Peoples R China

[43] Southern Med Univ, Shantou Univ Med Coll, Sch Clin Med 2, Guangdong Prov Peoples Hosp,Div Thorac Surg, Guangzhou, Peoples R China

[44] Southern Med Univ, Shantou Univ, Sch Clin Med 2, Guangdong Acad Med Sci,Med Coll, Guangzhou, Peoples R China

[45] Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Sch Med, Shanghai, Peoples R China

[46] Ningbo Univ, Lihuili Hosp, Dept Thorac Surg, Ningbo Med Ctr, Ningbo, Peoples R China

[47] Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R China

[48] Tianjin Chest Hosp, Dept Thorac Surg, Tianjin, Peoples R China

[49] Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp Southern 1, Dept Thorac Surg, Shenzhen, Peoples R China

[50] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2022年 / 11卷 / 09期

关键词：

NEOADJUVANT PEMBROLIZUMAB; HISTOPATHOLOGIC RESPONSE; PLUS CHEMOTHERAPY; SINGLE-ARM; OPEN-LABEL; LONG-TERM; NSCLC; SURVIVAL; SURGERY; ATEZOLIZUMAB;

D O I：

10.21037/tlcr-22-617

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1742 / 1762

页数：21

共 81 条

[41] Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome [J].

Lio, Jing ;

O'Donnell, Jake S. ;

Yan, Juming ;

Madore, Jason ;

Allen, Stacey ;

Smyth, Mark J. ;

Teng, Michele W. L. .

ONCOIMMUNOLOGY, 2019, 8 (05)

[42] Real-World Effectiveness and Prognostic Factors Analysis of Stages I-III Non-Small Cell Lung Cancer Following Neoadjuvant Chemo-Immunotherapy or Neoadjuvant Chemotherapy [J].

Liu, Zuo ;

Gao, Zhaoming ;

Zhang, Mengzhe ;

Wang, Xiaofei ;

Gong, Jialin ;

Jiang, Shuai ;

Zhang, Zhenfa .

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 28 (02) :111-120

[43] Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery [J].

Lopci, Egesta ;

Toschi, Luca ;

Grizzi, Fabio ;

Rahal, Daoud ;

Olivari, Laura ;

Castino, Giovanni Francesco ;

Marchetti, Silvia ;

Cortese, Nina ;

Qehajaj, Dorina ;

Pistillo, Daniela ;

Alloisio, Marco ;

Roncalli, Massimo ;

Allavena, Paola ;

Santoro, Armando ;

Marchesi, Federica ;

Chiti, Arturo .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (11) :1954-1961

[44] Surgical or medical strategy for locally-advanced, stage IIIA/B-N2 non-small cell lung cancer: Reproducibility of decision-making at a multidisciplinary tumor board [J].

Mainguene, Juliette ;

Basse, Clemence ;

Girard, Philippe ;

Beaucaire-Danel, Sophie ;

Cao, Kim ;

Brian, Emmanuel ;

Grigoroiu, Madalina ;

Gossot, Dominique ;

Luporsi, Marie ;

Perrot, Loic ;

Vieira, Thibault ;

Caliandro, Raffaele ;

Daniel, Catherine ;

Seguin-Givelet, Agathe ;

Girard, Nicolas .

LUNG CANCER, 2022, 163 :51-58

[45]

Masip JR, 2017, ANN ONCOL, V28, pv453

[46] Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer [J].

Moding, Everett J. ;

Liu, Yufei ;

Nabet, Barzin Y. ;

Chabon, Jacob J. ;

Chaudhuri, Aadel A. ;

Hui, Angela B. ;

Bonilla, Rene F. ;

Ko, Ryan B. ;

Yoo, Christopher H. ;

Gojenola, Linda ;

Jones, Carol D. ;

He, Jianzhong ;

Qiao, Yawei ;

Xu, Ting ;

Heymach, John V. ;

Tsao, Anne ;

Liao, Zhongxing ;

Gomez, Daniel R. ;

Das, Millie ;

Padda, Sukhmani K. ;

Ramchandran, Kavitha J. ;

Neal, Joel W. ;

Wakelee, Heather A. ;

Loo, Billy W., Jr. ;

Lin, Steven H. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

NATURE CANCER, 2020, 1 (02) :176-+

[47] Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial [J].

Mok, Tony S. K. ;

Wu, Yi-Long ;

Kudaba, Iveta ;

Kowalski, Dariusz M. ;

Cho, Byoung Chul ;

Turna, Hande Z. ;

Castro, Gilberto, Jr. ;

Srimuninnimit, Vichien ;

Laktionov, Konstantin K. ;

Bondarenko, Igor ;

Kubota, Kaoru ;

Lubiniecki, Gregory M. ;

Zhang, Jin ;

Kush, Debra ;

Lopes, Gilberto .

LANCET, 2019, 393 (10183) :1819-1830

[48] Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung Cancer [J].

Passaro, Antonio ;

Attili, Ilaria ;

de Marinis, Filippo .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (25) :2871-2022

[49] Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy [J].

Pataer, Apar ;

Kalhor, Neda ;

Correa, Arlene M. ;

Raso, Maria Gabriela ;

Erasmus, Jeremy J. ;

Kim, Edward S. ;

Behrens, Carmen ;

Lee, J. Jack ;

Roth, Jack A. ;

Stewart, David J. ;

Vaporciyan, Ara A. ;

Wistuba, Ignacio I. ;

Swisher, Stephen G. .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) :825-832

[50]

Paz-Ares L, 2022, 2022 ESMO VIRTUAL PL

← 1 2 3 4 5 6 7 8 9 →